Scribe Therapeutics Inc. (SCTX)
NASDAQ: SCTX · Real-Time Price · USD
23.03
+1.26 (5.79%)
At close: Sep 29, 2026, 4:00 PM EDT
23.04
+0.01 (0.04%)
After-hours: Sep 29, 2026, 7:30 PM EDT
Scribe Therapeutics Employees
Scribe Therapeutics had 82 employees as of June 30, 2026.
Employees
82
Change
n/a
Growth
n/a
Revenue / Employee
$406,122
Profits / Employee
-$393,951
Market Cap
436.00M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 82 | - | - |
| Mar 31, 2026 | 89 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ARS Pharmaceuticals | 200 |
| Arcturus Therapeutics Holdings | 111 |
| Editas Medicine | 87 |
| Prelude Therapeutics | 79 |
| Rezolute | 68 |
| Atea Pharmaceuticals | 55 |
| Zura Bio | 40 |
| Opus Genetics | 28 |
SCTX News
- 6 days ago - Cathie Wood’s ARK Investment buys 143.3K shares of Scribe Therapeutics today - TheFly
- 27 days ago - Scribe Therapeutics reports Q2 EPS ($2.62), consensus ($3.72) - TheFly
- 27 days ago - Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 27 days ago - Scribe Therapeutics Earnings release: Q2 2026 - Filings
- 27 days ago - Scribe Therapeutics Quarterly report: Q2 2026 - Filings
- 27 days ago - Scribe Therapeutics Slides: Investor presentation - Filings
- 4 weeks ago - Scribe Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Scribe Therapeutics initiated with a Buy at H.C. Wainwright - TheFly